» Articles » PMID: 33728276

Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role As a Therapeutic Agent

Overview
Publisher Dove Medical Press
Date 2021 Mar 17
PMID 33728276
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Soluble cytokine receptors can influence immune responses by modulating the biological functions of their respective ligands. These effects can be either agonistic or antagonistic and a number of soluble cytokine receptors have been shown to play critical roles in both maintenance of health and disease pathogenesis. Soluble IL-7Ra (sCD127) is one such example. With its impact on the IL-7/CD127 pathway, which is fundamental for the development and homeostasis of T cells, the role of sCD127 in health and disease has been extensively studied in recent years. Within this review, the role of sCD127 in maintaining host immune function is presented. Next, by addressing genetic factors affecting sCD127 expression and the associated levels of sCD127 production, the roles of sCD127 in autoimmune disease, infections and cancer are described. Finally, advances in the field of soluble cytokine therapy and the potential for sCD127 as a biomarker and therapeutic agent are discussed.

Citing Articles

Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity.

Tu T, Grunbaum A, Santinon F, Kazanova A, Rozza N, Kremer R Commun Biol. 2024; 7(1):526.

PMID: 38702425 PMC: 11068881. DOI: 10.1038/s42003-024-05922-2.


Prevalence of Selected Polymorphisms of Il7R, CD226, CAPSL, and CLEC16A Genes in Children and Adolescents with Autoimmune Thyroid Diseases.

Borysewicz-Sanczyk H, Wawrusiewicz-Kurylonek N, Goscik J, Sawicka B, Bossowski F, Corica D Int J Mol Sci. 2024; 25(7).

PMID: 38612837 PMC: 11012896. DOI: 10.3390/ijms25074028.


Novel Synonymous Variant in IL7R Causes Preferential Expression of the Soluble Isoform.

Mackeh R, El Bsat Y, Elmi A, Bibawi H, Karim M, Hassan A J Clin Immunol. 2024; 44(4):96.

PMID: 38587703 PMC: 11001715. DOI: 10.1007/s10875-024-01688-8.


Implication of IL-7 receptor alpha chain expression by CD8 T cells and its signature in defining biomarkers in aging.

Shin M, Park H, Young J, Kang I Immun Ageing. 2022; 19(1):66.

PMID: 36544153 PMC: 9768896. DOI: 10.1186/s12979-022-00324-6.


Antisense modulation of IL7R splicing to control sIL7R expression in human CD4 T cells.

Galarza-Munoz G, Kennedy-Boone D, Schott G, Bradrick S, Garcia-Blanco M RNA. 2022; 28(8):1058-1073.

PMID: 35613883 PMC: 9297843. DOI: 10.1261/rna.079137.122.

References
1.
Galarza-Munoz G, Briggs F, Evsyukova I, Schott-Lerner G, Kennedy E, Nyanhete T . Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk. Cell. 2017; 169(1):72-84.e13. PMC: 5456452. DOI: 10.1016/j.cell.2017.03.007. View

2.
Blokland S, Hillen M, Kruize A, Meller S, Homey B, Smithson G . Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis. Arthritis Rheumatol. 2017; 69(10):2038-2051. DOI: 10.1002/art.40182. View

3.
Majdinasab N, Hosseini Behbahani M, Galehdari H, Mohaghegh M . Association of interleukin 7 receptor gene polymorphism rs6897932 with multiple sclerosis patients in Khuzestan. Iran J Neurol. 2014; 13(3):168-71. PMC: 4240935. View

4.
Macpherson P, Fex C, Angel J . Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J Acquir Immune Defic Syndr. 2001; 28(5):454-7. DOI: 10.1097/00042560-200112150-00008. View

5.
Ghasemi N, Razavi S, Nikzad E . Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell J. 2017; 19(1):1-10. PMC: 5241505. DOI: 10.22074/cellj.2016.4867. View